Matches in Wikidata for { <http://www.wikidata.org/entity/Q84937632> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q84937632 description "artículu científicu espublizáu en payares de 2012" @default.
- Q84937632 description "scientific article published on 21 November 2012" @default.
- Q84937632 description "wetenschappelijk artikel" @default.
- Q84937632 description "наукова стаття, опублікована в листопаді 2012" @default.
- Q84937632 name "Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial" @default.
- Q84937632 name "Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial" @default.
- Q84937632 type Item @default.
- Q84937632 label "Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial" @default.
- Q84937632 label "Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial" @default.
- Q84937632 prefLabel "Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial" @default.
- Q84937632 prefLabel "Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial" @default.
- Q84937632 P1433 Q84937632-E58EF1EE-B72F-4349-83AD-0F24822D95CC @default.
- Q84937632 P1476 Q84937632-D854AE73-07C6-4F7B-B2F8-6F93B83946BB @default.
- Q84937632 P2093 Q84937632-042449EC-F2C2-4BE5-A60D-CE4A067EED4A @default.
- Q84937632 P2093 Q84937632-09E57FB5-59D3-4CDF-96D0-AB4CDF52E11F @default.
- Q84937632 P2093 Q84937632-206BEB88-B70A-441A-A4FD-91C8234BA09A @default.
- Q84937632 P2093 Q84937632-7BBCC370-A817-47AF-970A-FF0BA6441361 @default.
- Q84937632 P2093 Q84937632-937A0DA6-EEA4-4A52-AF03-FF521ADB73CC @default.
- Q84937632 P2093 Q84937632-95714758-F3C3-445E-97A9-5AAFE395A4B3 @default.
- Q84937632 P2093 Q84937632-A84EC31E-C1C6-4A1D-9256-0231BA58B85C @default.
- Q84937632 P2093 Q84937632-C76C1ACB-23E3-4192-A843-552407F53DF7 @default.
- Q84937632 P2093 Q84937632-CD9FAA79-02D3-498E-84F6-4DE45DE6447F @default.
- Q84937632 P2093 Q84937632-E0C62720-DE83-4590-BC2F-F9E0076E7282 @default.
- Q84937632 P2093 Q84937632-EA5D687A-E74A-45C1-A796-32A7612CED70 @default.
- Q84937632 P2093 Q84937632-FDDA661B-D6B1-43C7-86F3-D15CF1FA81FF @default.
- Q84937632 P304 Q84937632-ACC9F0D0-44BE-4EBF-805A-CA267BC7887E @default.
- Q84937632 P31 Q84937632-356973C9-2ED3-4F8E-A337-735919E7690C @default.
- Q84937632 P356 Q84937632-358D4310-29E7-47DF-AB94-B99C420E5EAA @default.
- Q84937632 P407 Q84937632-B7BAF495-9176-4E55-B9F9-4996D51CA4A4 @default.
- Q84937632 P433 Q84937632-00ABA4A3-7ECF-43E2-9B60-0F7D804ECE3A @default.
- Q84937632 P478 Q84937632-15A00611-A27C-4016-9258-DEB4A1832E72 @default.
- Q84937632 P50 Q84937632-0330F87F-E21E-49B6-8E1E-E07A46ED44E2 @default.
- Q84937632 P50 Q84937632-4A265F2D-725D-4CD4-978B-3CA704E4E0DF @default.
- Q84937632 P50 Q84937632-DC66F33D-06E3-4BB3-985A-58168A317872 @default.
- Q84937632 P50 Q84937632-E7D4AEFB-DADC-4050-ABF8-00CF162D756C @default.
- Q84937632 P50 Q84937632-F3985C3A-2936-49A1-894F-F35D1D663C78 @default.
- Q84937632 P577 Q84937632-33CF3E79-2815-4E13-A258-BDA47110FBCD @default.
- Q84937632 P698 Q84937632-A94AD3BF-B6FF-4D79-B364-7337010ED15F @default.
- Q84937632 P921 Q84937632-3A7108B1-7A8E-4AEA-A679-7892DA2E136F @default.
- Q84937632 P921 Q84937632-6B56E443-7FB6-4039-9209-44145DC601EE @default.
- Q84937632 P921 Q84937632-D0FEEB98-B8E1-4A25-8B8C-C9E790E14510 @default.
- Q84937632 P356 IJC.27819 @default.
- Q84937632 P698 22948952 @default.
- Q84937632 P1433 Q332492 @default.
- Q84937632 P1476 "Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial" @default.
- Q84937632 P2093 "A Rob P M Valentijn" @default.
- Q84937632 P2093 "Cornelis J H van de Velde" @default.
- Q84937632 P2093 "Eliane C M Zeestraten" @default.
- Q84937632 P2093 "Frank M Speetjens" @default.
- Q84937632 P2093 "Hans Gelderblom" @default.
- Q84937632 P2093 "Hans W Nijman" @default.
- Q84937632 P2093 "Jaap Oostendorp" @default.
- Q84937632 P2093 "Linda F M Stynenbosch" @default.
- Q84937632 P2093 "Lorraine M Fathers" @default.
- Q84937632 P2093 "Marij J P Welters" @default.
- Q84937632 P2093 "Rogier Jongen" @default.
- Q84937632 P2093 "Sepideh Saadatmand" @default.
- Q84937632 P304 "1581-1591" @default.
- Q84937632 P31 Q13442814 @default.
- Q84937632 P356 "10.1002/IJC.27819" @default.
- Q84937632 P407 Q1860 @default.
- Q84937632 P433 "7" @default.
- Q84937632 P478 "132" @default.
- Q84937632 P50 Q114408770 @default.
- Q84937632 P50 Q21552049 @default.
- Q84937632 P50 Q52982311 @default.
- Q84937632 P50 Q58280273 @default.
- Q84937632 P50 Q90315072 @default.
- Q84937632 P577 "2012-11-21T00:00:00Z" @default.
- Q84937632 P698 "22948952" @default.
- Q84937632 P921 Q188874 @default.
- Q84937632 P921 Q25493920 @default.
- Q84937632 P921 Q5452194 @default.